Evaluation of the Effects of Exenatide Administration in Patients with Type 2 Diabetes with Worsened Glycemic Control Caused by Glucocorticoid Therapy

Glucocorticoid-induced hyperglycemia is common in patients with or without known diabetes mellitus. Exenatide, a glucagon-like peptide-1 receptor agonist, improves glycemic control without causing weight gain or hypoglycemia and is currently widely used in patients with type 2 diabetes mellitus. We...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Internal Medicine 2013, Vol.52(1), pp.89-95
Hauptverfasser:	Matsuo, Koji, Nambu, Takuo, Matsuda, Yuki, Kanai, Yugo, Yonemitsu, Shin, Muro, Seiji, Oki, Shogo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Blood Glucose - analysis Blood Glucose - drug effects diabetes mellitus Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - drug therapy Dose-Response Relationship, Drug Drug Administration Schedule Exenatide Female Follow-Up Studies glucocorticoids Glucocorticoids - adverse effects Glucocorticoids - therapeutic use Humans Hyperglycemia - chemically induced Hyperglycemia - drug therapy Hyperglycemia - physiopathology Hypoglycemic Agents - therapeutic use incretin Injections, Subcutaneous Insulin - therapeutic use Male Middle Aged Peptides - therapeutic use Risk Assessment Sampling Studies Treatment Outcome Venoms - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!